EZH2 and breast carcinoma: We report for the first time that DANCR essentially contributed to all three malignant phenotypes of breast cancer, which, on the molecular level, was mediated through EZH2‐controlled epigenetic regulation of suppressor of cytokine signaling 3 (SOCS3) via H3K27 trimethylation.